SKI Market

A+| A| A-|

Indian Indices

Sensex

78,493.54 504.86
( 0.65%)

Global Indices

Nasdaq

49,467.44 867.71
(1.79%)

Dow Jones

7,146.92 84.64
(1.20%)

Hang Seng

58,837.37 -680.97
(-1.14%)

Nikkei 225

10,660.47 70.48
(0.67%)

Forex

USD-INR

93.19 -0.12
(-0.13%)

EUR-INR

109.85 -0.18
(-0.16%)

GBP-INR

126.25 -0.31
(-0.25%)

JPY-INR

0.59 0.00
(-0.15%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Industry :

BSE Code

ISIN Demat

Book Value()

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

EPS(TTM)

Face Value()

Div & Yield %

Back

fischer medical ventures ltd

Glaxosmithkline Pharmaceuticals consolidated net profit rises 1.98% in the September 2025 quarter

Nov 06,2025

Net profit of Glaxosmithkline Pharmaceuticals rose 1.98% to Rs 257.49 crore in the quarter ended September 2025 as against Rs 252.50 crore during the previous quarter ended September 2024. Sales declined 3.05% to Rs 979.94 crore in the quarter ended September 2025 as against Rs 1010.77 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	979.94	1010.77	-3
OPM %	34.26	31.83	-
PBDT	368.79	355.98	4
PBT	351.36	339.12	4
NP	257.49	252.50	2

78,493.54 504.86 ( 0.65%)

49,467.44 867.71 (1.79%)

7,146.92 84.64 (1.20%)

58,837.37 -680.97 (-1.14%)

10,660.47 70.48 (0.67%)

93.19 -0.12 (-0.13%)

109.85 -0.18 (-0.16%)

126.25 -0.31 (-0.25%)

0.59 0.00 (-0.15%)